Unknown

Dataset Information

0

APOE ?4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.


ABSTRACT: This study was designed to explore the influence of apolipoprotein E (APOE) on blood phospholipids (PL) in predicting preclinical Alzheimer's disease (AD). Lipidomic analyses were also performed on blood from an AD mouse model expressing human APOE isoforms (EFAD) and five AD mutations and from 195 cognitively normal participants, 23 of who converted to mild cognitive impairment (MCI)/AD within 3 years. APOE ?4-carriers converting to MCI/AD had high arachidonic acid (AA)/docosahexaenoic acid (DHA) ratios in PL compared to cognitively normal ?4 and non-?4 carriers. Arachidonic acid and DHA containing PL species, ?4-status and A?42/A?40 ratios provided 91% accuracy in detecting MCI/AD. Fish oil/omega-3 fatty acid consumption was associated with lower AA/DHA ratios even among ?4 carriers. High plasma AA/DHA ratios were observed in E4FAD compared to EFAD mice with other isoforms. In particular, alterations in plasma AA and DHA containing PL species were also observed in the brains of E4FAD mice compared to E3FAD mice. Despite the small sample size and a short follow-up, these results suggest that blood PL could potentially serve as biomarkers of preclinical MCI/AD.

SUBMITTER: Abdullah L 

PROVIDER: S-EPMC5391242 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.

Abdullah Laila L   Evans James E JE   Emmerich Tanja T   Crynen Gogce G   Shackleton Ben B   Keegan Andrew P AP   Luis Cheryl C   Tai Leon L   LaDu Mary J MJ   Mullan Michael M   Crawford Fiona F   Bachmeier Corbin C  

Aging 20170301 3


This study was designed to explore the influence of apolipoprotein E (APOE) on blood phospholipids (PL) in predicting preclinical Alzheimer's disease (AD). Lipidomic analyses were also performed on blood from an AD mouse model expressing human APOE isoforms (EFAD) and five AD mutations and from 195 cognitively normal participants, 23 of who converted to mild cognitive impairment (MCI)/AD within 3 years. APOE ε4-carriers converting to MCI/AD had high arachidonic acid (AA)/docosahexaenoic acid (DH  ...[more]

Similar Datasets

| S-EPMC8112902 | biostudies-literature
| S-EPMC3316678 | biostudies-literature
| S-EPMC3208738 | biostudies-literature
| S-EPMC8406896 | biostudies-literature
| S-EPMC5434145 | biostudies-literature
| S-EPMC5972633 | biostudies-literature
| S-EPMC7156328 | biostudies-literature
| S-EPMC6449776 | biostudies-literature
| S-EPMC7078098 | biostudies-literature
| S-EPMC9313258 | biostudies-literature